MarketBeat reported the average rating for Cellectis on August 7, 2026.
2 reports, 1 independent
Updated Aug 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported the average rating for Cellectis on August 7, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Cellectis
biopharmaceutical company
Nothing else this week.
Related events
- MarketBeat provided average rating data for Bluejay Diagnostics, Inc. on October 22, 2026.
- Alset Inc. filed reports with the Securities and Exchange Commission, and MarketBeat reported its average stock rating.
- MarketBeat was used to provide rating data for Cresco Labs on August 5, 2026.
- MarketBeat provided average stock rating data for SS Innovations International, Inc. on June 6, 2026.
- MarketBeat provided recent stock ratings for the company Phibro.